This bill establishes a comprehensive federal research and response program for Long COVID, a condition affecting many people who experience prolonged symptoms after COVID-19 infection. The legislation creates a dedicated Long COVID Research Program within the National Institutes of Health, headed by a Director who will coordinate all federal research efforts and work with patient advocacy groups. The program will investigate the causes and treatments of Long COVID, develop a detailed research plan, and establish an advisory board that includes patients, caregivers, and health experts to guide research priorities and funding decisions.
The bill authorizes one billion dollars annually from 2025 through 2034 for the research program itself, with additional funding for related activities including CDC surveillance and public education campaigns, healthcare provider training, and development of Long COVID clinics to provide coordinated care. Key provisions include fast-tracked grant applications with 120-day approval timelines, priority funding for treatments already being tested and interventions for children, and requirements that any drugs or devices developed with federal funding be priced reasonably and competitively. The legislation also supports data collection efforts, clinical guidelines for providers, and special attention to vulnerable populations including children and historically underserved communities affected by Long COVID.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.